Darryl Wellinghoff Insider Trading $LJPC LA JOLLA PHARMACEUTICAL CO
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Darryl Wellinghoff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Darryl Wellinghoff. Darryl Wellinghoff is Chief Commercial Officer in LA JOLLA PHARMACEUTICAL CO ($LJPC).
Darryl Wellinghoff in LA JOLLA PHARMACEUTICAL CO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Darryl Wellinghoff: Chief Commercial Officer
Holdings: 9,504 shares
Current Value: $185,043
Latest Transaction: Apr 17 2020
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Darryl Wellinghoff in LA JOLLA PHARMACEUTICAL CO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.60 | 34 | 224 | 34 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.61 | 34 | 191 | 9,504 | 9.5 K to 9.5 K (+0.36 %) |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 4.20 | 459 | 1,928 | 459 | |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 3.57 | 459 | 1,639 | 9,470 | 9 K to 9.5 K (+5.09 %) |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 4.00 | 483 | 1,932 | 483 | |
| Mar 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 3.40 | 483 | 1,642 | 9,011 | 8.5 K to 9 K (+5.66 %) |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.80 | 284 | 1,931 | 284 | |
| Mar 03 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.78 | 284 | 1,642 | 8,528 | 8.2 K to 8.5 K (+3.44 %) |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.40 | 229 | 1,924 | 229 | |
| Feb 19 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.14 | 229 | 1,635 | 8,244 | 8 K to 8.2 K (+2.86 %) |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.85 | 282 | 1,932 | 282 | |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.82 | 282 | 1,641 | 8,015 | 7.7 K to 8 K (+3.65 %) |
| Jan 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Buy | P | 8.23 | 3,000 | 24,677 | 6,545 | 3.5 K to 6.5 K (+84.63 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 2.74 | 17 | 47 | 17 | |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 2.33 | 17 | 40 | 3,545 | 3.5 K to 3.5 K (+0.48 %) |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.02 | 311 | 1,872 | 311 | |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.12 | 311 | 1,592 | 3,528 | 3.2 K to 3.5 K (+9.67 %) |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 7.02 | 267 | 1,874 | 267 | |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.96 | 267 | 1,591 | 3,217 | 3 K to 3.2 K (+9.05 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.38 | 224 | 1,877 | 224 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.12 | 224 | 1,595 | 2,950 | 2.7 K to 3 K (+8.22 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.80 | 213 | 1,874 | 213 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.48 | 213 | 1,593 | 2,726 | 2.5 K to 2.7 K (+8.48 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 10.92 | 171 | 1,867 | 171 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 9.28 | 171 | 1,587 | 2,513 | 2.3 K to 2.5 K (+7.30 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.57 | 196 | 1,876 | 196 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.13 | 196 | 1,593 | 2,342 | 2.1 K to 2.3 K (+9.13 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.43 | 198 | 1,867 | 198 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.02 | 198 | 1,588 | 2,146 | 1.9 K to 2.1 K (+10.16 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.36 | 224 | 1,873 | 224 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.11 | 224 | 1,593 | 1,948 | 1.7 K to 1.9 K (+12.99 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.24 | 203 | 1,876 | 203 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.85 | 203 | 1,594 | 1,724 | 1.5 K to 1.7 K (+13.35 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.25 | 202 | 1,869 | 202 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.86 | 202 | 1,588 | 1,521 | 1.3 K to 1.5 K (+15.31 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.71 | 193 | 1,874 | 193 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.25 | 193 | 1,592 | 1,319 | 1.1 K to 1.3 K (+17.14 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 5.39 | 347 | 1,870 | 347 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 4.58 | 347 | 1,589 | 1,126 | 779 to 1.1 K (+44.54 %) |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.57 | 285 | 1,872 | 285 | |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.58 | 285 | 1,590 | 779 | 494 to 779 (+57.69 %) |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.05 | 233 | 1,876 | 233 | |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 6.84 | 233 | 1,594 | 494 | 261 to 494 (+89.27 %) |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 7.16 | 261 | 1,869 | 261 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 6.09 | 261 | 1,589 | 261 | 0 to 261 |
Page: 1